Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117166962 | 11716696 | 2 | F | 201101 | 20160718 | 20151109 | 20160725 | EXP | US-DSJP-DSU-2015-120851 | DAIICHI | 0.00 | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117166962 | 11716696 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | Y | UNKNOWN | 21286 | 20 | MG | TABLET | QD | ||||
| 117166962 | 11716696 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Y | 21286 | TABLET | ||||||||||
| 117166962 | 11716696 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40MG/25MG, BID | Y | UNKNOWN | 0 | 1 | DF | FILM-COATED TABLET | BID | ||||
| 117166962 | 11716696 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Y | 0 | FILM-COATED TABLET | ||||||||||
| 117166962 | 11716696 | 5 | C | LASIX | FUROSEMIDE | 1 | 20 MG, PRN | 0 | 20 | MG | |||||||||
| 117166962 | 11716696 | 6 | C | OXYCODONE | OXYCODONE | 1 | 15 MG, UNK | 0 | 15 | MG | |||||||||
| 117166962 | 11716696 | 7 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | 30 MG, QID | 0 | 30 | MG | QID | ||||||||
| 117166962 | 11716696 | 8 | C | OPANA | OXYMORPHONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 9 | C | OPANA | OXYMORPHONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117166962 | 11716696 | 10 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 11 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 117166962 | 11716696 | 12 | C | VALISONE | BETAMETHASONE VALERATE | 1 | UNK | 0 | CREAM | ||||||||||
| 117166962 | 11716696 | 13 | C | VALISONE | BETAMETHASONE VALERATE | 1 | 0 | CREAM | |||||||||||
| 117166962 | 11716696 | 14 | C | PREVACID | LANSOPRAZOLE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 117166962 | 11716696 | 15 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 40 MG, BID | 0 | 40 | MG | BID | ||||||||
| 117166962 | 11716696 | 16 | C | CEPHALEXINE | CEPHALEXIN | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 17 | C | MAGNESIUM | MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 18 | C | POTASSIUM CL | POTASSIUM CHLORIDE | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 19 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 20 | C | LACTULOSE. | LACTULOSE | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 21 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | UNK | 0 | |||||||||||
| 117166962 | 11716696 | 22 | C | THIAMINE. | THIAMINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117166962 | 11716696 | 1 | Hypertension |
| 117166962 | 11716696 | 2 | Headache |
| 117166962 | 11716696 | 3 | Headache |
| 117166962 | 11716696 | 4 | Hypertension |
| 117166962 | 11716696 | 5 | Oedema peripheral |
| 117166962 | 11716696 | 6 | Back pain |
| 117166962 | 11716696 | 7 | Pain |
| 117166962 | 11716696 | 8 | Back pain |
| 117166962 | 11716696 | 9 | Pain |
| 117166962 | 11716696 | 10 | Intervertebral disc degeneration |
| 117166962 | 11716696 | 11 | Back pain |
| 117166962 | 11716696 | 12 | Dermatitis |
| 117166962 | 11716696 | 13 | Pruritus |
| 117166962 | 11716696 | 14 | Gastrooesophageal reflux disease |
| 117166962 | 11716696 | 15 | Pain |
| 117166962 | 11716696 | 16 | Product used for unknown indication |
| 117166962 | 11716696 | 17 | Product used for unknown indication |
| 117166962 | 11716696 | 18 | Product used for unknown indication |
| 117166962 | 11716696 | 19 | Product used for unknown indication |
| 117166962 | 11716696 | 20 | Product used for unknown indication |
| 117166962 | 11716696 | 21 | Product used for unknown indication |
| 117166962 | 11716696 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117166962 | 11716696 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117166962 | 11716696 | Acute kidney injury | |
| 117166962 | 11716696 | Adenoma benign | |
| 117166962 | 11716696 | Large intestine polyp | |
| 117166962 | 11716696 | Malabsorption | |
| 117166962 | 11716696 | Muscle fatigue | |
| 117166962 | 11716696 | Poverty of speech | |
| 117166962 | 11716696 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117166962 | 11716696 | 1 | 200206 | 200411 | 0 | |
| 117166962 | 11716696 | 3 | 200411 | 201204 | 0 | |
| 117166962 | 11716696 | 5 | 201202 | 0 | ||
| 117166962 | 11716696 | 8 | 201105 | 201203 | 0 | |
| 117166962 | 11716696 | 12 | 201108 | 201201 | 0 | |
| 117166962 | 11716696 | 14 | 2006 | 2009 | 0 | |
| 117166962 | 11716696 | 21 | 201202 | 201203 | 0 |